According to two prostate cancer studies from Taylor and TCGA, lower expression levels of CES1 were associated with prostate cancer, a higher Gleason score, a more advanced stage, and worse survival in patients (Figure 2B,C). The gene discussed is CES1; the disease is prostate cancer.